You are here: Industry Insights > Development

News List

Mereo BioPharma Appoints Head of Pharma Development contractpharma
July 17, 2019
Richard Francis brings more than 35 years of experience in biopharmaceutical process development and manufacturing operations.
Digital design for pharmaceutical product and process development europeanpharmaceuticalreview
July 05, 2019
Digital design for pharmaceutical product and process development.
Asieris, Photocure Enter into License Agreement for Cevira Development americanpharmaceuticalreview
July 03, 2019
Asieris MediTech and Photocure announced they have entered into a License Agreement for world-wide development and commercialization of Cevira® for the treatment of HPV induced cervical precancerous lesions.
Seqens Unveils Innovation and Development CoE contractpharma
June 21, 2019
SEQENS'Lab is a development accelerator located just out of Paris.
Mill Creek Life Sciences Receives Grant for Development of Dendritic Cell Vaccine americanpharmaceuticalreview
June 20, 2019
Mill Creek Life Sciences has received a one-year $100,000 grant from Regenerative Medicine Minnesota (RMM) titled: "Development of Technology for the Large-scale Production of a Novel Dendritic Cell Vaccine for the Treatment of Glioblastoma."
Evotec Receives $23.8M TB Grant contractpharma
June 12, 2019
Aims to generate standardized, high-quality preclinical data to support novel regimen selection and development.
Deloitte finds Pharma returns on R&D reach new low europeanpharmaceuticalreview
April 16, 2019
Deloitte finds Pharma returns on R&D reach new low.
I-Mab, Nhwa and CDMO Biodextris Enter Research Collaboration contractpharma
April 15, 2019
Together and along with a Boston-based academic medical center will jointly develop a novel immuno-stimulatory therapy for neurologic disorders...
Diversifying drug development with a metal catalyst europeanpharmaceuticalreview
April 10, 2019
Researchers have outlined a method of formulating drug-like aliphatic and aromatic carbon-hydrogen scaffolds into drugs using a metal catalyst…
Puma Biotechnology and Pierre Fabre enter into an exclusive license agreement for the development and marketing of NERLYNX® (neratinib) pharmafocusasia
April 03, 2019
Puma Biotechnology, Inc and Pierre Fabre have entered into an exclusive license agreement under which Pierre Fabre will develop and market NERLYNX® (neratinib) in Europe and in some regions of Africa. In September 2018...

Previous page 1 2 3 4 5 6 7 Next page